Jones Trading Starts Dyne Therapeutics (DYN) at Buy

Jones Trading initiates coverage on Dyne Therapeutics (NASDAQ: DYN) with a Buy rating and a price target of $45.00.

For an analyst ratings summary and ratings history on Dyne Therapeutics click here. For more ratings news on Dyne Therapeutics click here.

Shares of Dyne Therapeutics closed at $20.31 yesterday.

You May Also Be Interested In

• Lake Street Capital Markets Starts Research Solutions Inc. (RSSS) at Buy
• William Blair Starts First Advantage (FA) at Outperform, 'Best-in-Class Background Screener'
• Canaccord Genuity Starts Pan African Resources PLC (PAF:LN) at Buy